慢性血栓栓塞性肺动脉高压患者肺灌注SPECT中肺容积标准化SUV的效用
本研究为单中心回顾性研究,纳入58例患者(推导队列39例:慢性血栓栓塞性肺动脉高压25例、对照14例;验证队列19例),评估肺灌注SPECT/CT中经CT衰减校正扫描以肺容积标准化的摄取值(SUVLV)与按体重标准化的常规SUV(SUVBW)相比的可靠性。结果显示SUVLV在人群和治疗阶段间保持一致(0.88–0.90,P=0.565),而SUVBW显著变化(17.8–25.8,P<0.001);SUVLV≤0.7的肺容积分数与平均肺动脉压强相关(r=0.632,P<0.001),验证队列中该分数截止值50.1%预测mPAP>20 mmHg的敏感度和特异度均为100%。结论认为SUVLV是可靠的定量指标,可能改善CTEPH疾病严重度和治疗反应的评估。
要点
- SUVLV在人群和治疗阶段间保持一致(0.88–0.90,P=0.565),而SUVBW显著变化(17.8–25.8,P<0.001)。
- SUVLV≤0.7的肺容积分数与mPAP强相关(r=0.632,P<0.001),并随成功BPA和mPAP改善而逐渐降低。
- 验证队列中SUVLV≤0.7的肺容积分数截止值50.1%预测mPAP>20 mmHg的敏感度和特异度均为100%。
核心结论
- SUVLV是与SUVBW相比可靠的SPECT/CT-LPI定量指标,可能改善CTEPH患者疾病严重度和治疗反应的个体内与个体间评估。
研究设计与样本
- 单中心回顾性研究,纳入58例患者,其中推导队列39例(慢性血栓栓塞性肺动脉高压25例、对照14例),验证队列19例。
- 推导队列在基线、初次随访和完成BPA后行SPECT/CT-LPI和右心导管检查,研究SUVLV最佳阈值下与mPAP相关的肺容积分数。
- 验证队列评估SUVLV预测mPAP>20 mmHg的诊断性能。
主要发现
- 平均SUVLV在不同人群和治疗阶段间保持一致(0.88–0.90,P=0.565),而平均SUVBW显著变化(17.8–25.8,P<0.001)。
- SUVLV≤0.7的肺容积分数与mPAP强相关(r=0.632,P<0.001),并随成功BPA和mPAP改善而逐渐降低。
- 验证队列中SUVLV≤0.7的肺容积分数截止值50.1%预测mPAP>20 mmHg的敏感度和特异度均为100%。
关键数值与推荐
- SUVLV≤0.7的肺容积分数与mPAP的相关系数r=0.632(P<0.001)。
- 验证队列中SUVLV≤0.7的肺容积分数截止值50.1%预测mPAP>20 mmHg的敏感度100%、特异度100%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The standardized uptake value (SUV) can be measured by single-photon emission computed tomography with computed tomography (SPECT/CT) to provide a quantitative assessment; however, it has not been utilized in lung perfusion imaging (LPI). Since Tc-99m MAA is primarily trapped in the lungs, we hypothesized that the SUV normalized to lung volume using CT attenuation correction scans (SUVLV) might offer a more reliable evaluation than the conventional SUV normalized to body weight (SUVBW). METHODS: This single-center retrospective study included 58 patients (39 derivation cohorts: 25 patients with chronic thromboembolic pulmonary hypertension (CTEPH) and 14 controls; 19 validation cohorts). SPECT/CT-LPI and right heart catheterization were performed at baseline, initial follow-up, and after completing BPA in the derivation cohort. The lung volume fractions below optimal SUV thresholds that optimally correlated with mean pulmonary arterial pressure (mPAP) were investigated. The diagnostic performance of SUVLV was evaluated to predict mPAP >20 mm Hg in the validation cohort. RESULTS: Mean SUVLV remained consistent (0.88-0.90, P=0.565) across populations and treatment stages, whereas mean SUVBW varied significantly (17.8-25.8, P<0.001). Lung volume fraction with SUVLV ≤0.7 exhibited a strong correlation with mPAP (r=0.632, P<0.001) and decreased progressively with successful BPA and mPAP improvement. In the validation cohort, a cutoff value of lung volume fraction of 50.1% with SUVLV≤0.7 demonstrated 100% sensitivity and specificity for predicting mPAP >20 mm Hg. CONCLUSIONS: SUVLV is a reliable quantitative measure for SPECT/CT-LPI compared with SUVBW and may enhance intrapatient and interpatient assessments of disease severity and treatment response in CTEPH.
引用
- Kuronuma K, Miyagi A, Takahashi K, et al. Utility of Lung Volume-normalized SUV on Lung Perfusion SPECT in Patients With Chronic Thromboembolic Pulmonary Hypertension. Clin Nucl Med. 2025. PMID: 40462322. doi:10.1097/RLU.0000000000005919
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。